These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Use of N-methylpiperazine for the preparation of piperazine-based unsymmetrical bis-ureas as anti-HIV agents. El-Faham A; Armand-Ugón M; Esté JA; Albericio F ChemMedChem; 2008 Jul; 3(7):1034-7. PubMed ID: 18383064 [No Abstract] [Full Text] [Related]
46. Synthesis of dammarane-type triterpene derivatives and their ability to inhibit HIV and HCV proteases. Wei Y; Ma CM; Hattori M Bioorg Med Chem; 2009 Apr; 17(8):3003-10. PubMed ID: 19339186 [TBL] [Abstract][Full Text] [Related]
47. Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs). Lin Y; Liu X; Yan R; Li J; Pannecouque C; Witvrouw M; De Clercq E Bioorg Med Chem; 2008 Jan; 16(1):157-63. PubMed ID: 17964796 [TBL] [Abstract][Full Text] [Related]
49. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues. Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120 [TBL] [Abstract][Full Text] [Related]
51. Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development. François KO; Auwerx J; Schols D; Balzarini J Mol Pharmacol; 2008 Aug; 74(2):330-7. PubMed ID: 18474667 [TBL] [Abstract][Full Text] [Related]
52. Epsilon substituted lysinol derivatives as HIV-1 protease inhibitors. Jones KL; Holloway MK; Su HP; Carroll SS; Burlein C; Touch S; DiStefano DJ; Sanchez RI; Williams TM; Vacca JP; Coburn CA Bioorg Med Chem Lett; 2010 Jul; 20(14):4065-8. PubMed ID: 20547452 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological evaluation of novel isopropanolamine derivatives as non-peptide human immunodeficiency virus protease inhibitors. Zhou L; Yang Q; Wang Y; Hu Y; Luo X; Bai D; Li S Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1147-52. PubMed ID: 18670116 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and in vitro biological evaluation of mannose-containing prodrugs derived from clinically used HIV-protease inhibitors with improved transepithelial transport. Roche D; Greiner J; Aubertin AM; Vierling P Bioconjug Chem; 2006; 17(6):1568-81. PubMed ID: 17105238 [TBL] [Abstract][Full Text] [Related]
55. 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Zhan P; Liu X; Cao Y; Wang Y; Pannecouque C; De Clercq E Bioorg Med Chem Lett; 2008 Oct; 18(20):5368-71. PubMed ID: 18824350 [TBL] [Abstract][Full Text] [Related]
56. 1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors. Brik A; Alexandratos J; Lin YC; Elder JH; Olson AJ; Wlodawer A; Goodsell DS; Wong CH Chembiochem; 2005 Jul; 6(7):1167-9. PubMed ID: 15934050 [No Abstract] [Full Text] [Related]
57. Topological models for the prediction of HIV-protease inhibitory activity of tetrahydropyrimidin-2-ones. Lather V; Madan AK J Mol Graph Model; 2005 Jan; 23(4):339-45. PubMed ID: 15670954 [TBL] [Abstract][Full Text] [Related]
59. 4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters. Hagen SE; Domagala J; Gajda C; Lovdahl M; Tait BD; Wise E; Holler T; Hupe D; Nouhan C; Urumov A; Zeikus G; Zeikus E; Lunney EA; Pavlovsky A; Gracheck SJ; Saunders J; VanderRoest S; Brodfuehrer J J Med Chem; 2001 Jul; 44(14):2319-32. PubMed ID: 11428926 [TBL] [Abstract][Full Text] [Related]
60. A new class of HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold. Ekegren JK; Unge T; Safa MZ; Wallberg H; Samuelsson B; Hallberg A J Med Chem; 2005 Dec; 48(25):8098-102. PubMed ID: 16335934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]